Back to JBIO

Affinity Asset Advisors, LLC → JBIO

Affinity Asset Advisors, LLC JBIO Position History

Jade Biosciences, Inc. • Healthcare

Quarters held
4
Latest value
$10.7M
Q3 2026
Peak value
$18.7M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$11M
Q1 2026$9M
Q2 2026$18.7M
Q3 2026$10.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$10.7M760.4K——
Q2 2026$18.7M840.4K——
Q1 2026$9M640.0K——
Q4 2025$11M715.0K——

Other funds holding JBIO

Other Affinity Asset Advisors, LLC positions

ROIV

ROIVANT SCIENCES LTD

$132.7M
APGE

APOGEE THERAPEUTICS INC

$131M
ROIV

ROIVANT SCIENCES LTD

$117M
SYRE

SPYRE THERAPEUTICS INC

$113.9M
SYRE

SPYRE THERAPEUTICS INC

$113.6M
APGE

APOGEE THERAPEUTICS INC

$108.2M
XENE

XENON PHARMACEUTICALS INC

$97.4M
XENE

XENON PHARMACEUTICALS INC

$96.3M